Andreas Seiter
About
In The Last Decade
Andreas Seiter
17 papers receiving 259 citations
Peers
Comparison fields: 5 of 74
- Economics and Econometrics 186
- Public Health, Environmental and Occupational Health 71
- General Health Professions 69
- Pediatrics, Perinatology and Child Health 64
- Finance 63
Countries citing papers authored by Andreas Seiter
This map shows the geographic impact of Andreas Seiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Seiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Seiter more than expected).
Fields of papers citing papers by Andreas Seiter
This network shows the impact of papers produced by Andreas Seiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Seiter. The network helps show where Andreas Seiter may publish in the future.
Co-authorship network of co-authors of Andreas Seiter
This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Seiter. A scholar is included among the top collaborators of Andreas Seiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Seiter. Andreas Seiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 4 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 118 | |
| 6 | 2 | |
| 7 | A Practical Approach to
\n Pharmaceutical Policy | 43 |
| 8 | 11 | |
| 9 | 5 | |
| 10 | 17 | |
| 11 | 28 | |
| 12 | 15 | |
| 13 | Private sector pharmaceutical supply and distribution chains : Ghana, Mali, and Malawi | 4 |
| 14 | 5 | |
| 15 | 14 | |
| 16 | Pharmaceutical: counterfeits, substandard drugs and drug diversion | 1 |
| 17 | Pharmaceuticals: cost containment, pricing, reimbursement | 1 |
| 18 | Pharmaceuticals: local manufacturing | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.